Diabetes mellitus. Insulin-dependent diabetes mellitus and Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: 60 patients with type 1 and 2 diabetes will enrolled in this prospective randomized clinical trial study, these patients are divided randomly in two 30 person groups. In case group, No
Treatment - Drugs
60 patients with type 1 and 2 diabetes will enrolled in this prospective randomized clinical trial study, these patients are divided randomly in two 30 person groups. In case group, Novomix® insulin w
60 patients with type 1 and 2 diabetes will enrolled in this prospective randomized clinical trial study, these patients are divided randomly in two 30 person groups. In control group, NPH insulin wou
Sponsors
Tehran Univeristy of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Male or female patients with type 1 and 2 diabetes; diabetic patients who are inadequately controlled blood glucose on their previous therapy that have HbA1c< 10%; diabetic patients who are administrated with Novomix or NPH. Exclusion criteria:Patients occurrence of sever side–effects; suffering from diabetes in pregnancy; any refuse to participate in study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c. Timepoint: every 3 months. Method of measurement: laboratory tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| Costs of treatments. Timepoint: At the end of the study. Method of measurement: Economic evaluations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Farshchi
Tehran University of Medical Sciences
Outcome results
None listed